The practice at Latham & Watkins represents prominent companies in complex trade secrets litigation, often involving high-stakes issues. Team members regularly handle misappropriation of business-critical information, breach of contract, and restrictive covenants, obtaining dismissals, injunctions, and high-value damage relief. Michael Morin and David Frazier co-lead the group from Washington DC, with a great track record in high-profile mandates such as the 'Botox wars'; Charles Sanders and Patricia Young co-head from Boston and Silicon Valley, respectively. Key members are San Diego's Jennifer Barry, whose portfolio of clients includes global industry leaders; New York-based Anthony Sammi and Rachel Renee Blitzer, highly commendable in trials; and Matthew Walch in Chicago, who also supports with trademark mandates. Jeff Homrig and Douglas Lumish departed the firm in July 2025.
Legal 500 Editorial commentary
Accolades
Client satisfaction: Sector knowledge
Client satisfaction: NPS ®
Key clients
- AbbVie Inc.
- ArcLight Capital Partners LLC
- Avadel CNS Pharmaceuticals, LLC
- Balt Inc.
- CCC Intelligent Solutions Inc.
- CoStar Group, Inc.
- Hyundai America Technical Center Inc. (HATCI)
- MirrorWeb
- XP Power LLC
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Next Generation Partners
Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.
Practice head
Michael Morin; David Frazier; Charles Sanders; Patricia Young
Other key lawyers
Jennifer Barry; Anthony Sammi; Rachel Renee Blitzer; Matthew Walch